197 related articles for article (PubMed ID: 20851413)
1. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.
Moriya F; Ogasawara S; Basaki Y; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Nishida N; Matsuoka K; Kojiro M; Kuwano M; Yano H
Int J Oncol; 2008 Oct; 33(4):647-55. PubMed ID: 18813777
[TBL] [Abstract][Full Text] [Related]
4. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155.
Zhang Y; Li X; Zhang Y; Wang L; Xu J; Du J; Guan Y
Ann Hepatol; 2019; 18(3):494-500. PubMed ID: 31036495
[TBL] [Abstract][Full Text] [Related]
5. Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.
Kusano H; Akiba J; Ogasawara S; Sanada S; Yasumoto M; Nakayama M; Ueda K; Ueda K; Kurita T; Todoroki K; Umeno Y; Nakashima O; Yano H
PLoS One; 2013; 8(12):e83195. PubMed ID: 24349459
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of sorafenib and pegylated IFN‑α2b on human liver cancer cells in vitro and in vivo.
Kusano H; Ogasawara S; Akiba J; Nakayama M; Ueda K; Yano H
Int J Oncol; 2013 Jun; 42(6):1897-903. PubMed ID: 23588838
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.
Lee D; Chung YH; Kim JA; Park WH; Jin YJ; Shim JH; Ryu SH; Jang MK; Yu E; Lee YJ
Cancer; 2013 Jun; 119(12):2239-46. PubMed ID: 23564564
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
9. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
[TBL] [Abstract][Full Text] [Related]
10. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
11. Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Yano H; Basaki Y; Oie S; Ogasawara S; Momosaki S; Akiba J; Nishida N; Kojiro S; Ishizaki H; Moriya F; Kuratomi K; Fukahori S; Kuwano M; Kojiro M
J Interferon Cytokine Res; 2007 Mar; 27(3):231-8. PubMed ID: 17348822
[TBL] [Abstract][Full Text] [Related]
12. Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.
Escudero A; Rodríguez F; Serra MA; Del Olmo JA; Montes F; Rodrigo JM
J Gastroenterol Hepatol; 2008 Jun; 23(6):861-6. PubMed ID: 18422960
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
Berenguer J; González-García J; López-Aldeguer J; Von-Wichmann MA; Quereda C; Hernando A; Sanz J; Tural C; Ortega E; Mallolas J; Santos I; Miralles P; Montes ML; Bellón JM; Esteban H;
J Antimicrob Chemother; 2009 Jun; 63(6):1256-63. PubMed ID: 19363085
[TBL] [Abstract][Full Text] [Related]
14. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
16. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
17. Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection.
Tanimoto Y; Tashiro H; Aikata H; Amano H; Oshita A; Kobayashi T; Kuroda S; Tazawa H; Takahashi S; Itamoto T; Chayama K; Ohdan H
Ann Surg Oncol; 2012 Feb; 19(2):418-25. PubMed ID: 21710324
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
Huang SF; Kim SJ; Lee AT; Karashima T; Bucana C; Kedar D; Sweeney P; Mian B; Fan D; Shepherd D; Fidler IJ; Dinney CP; Killion JJ
Cancer Res; 2002 Oct; 62(20):5720-6. PubMed ID: 12384530
[TBL] [Abstract][Full Text] [Related]
19. Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.
Thompson MD; Dar MJ; Monga SP
J Hepatol; 2011 Mar; 54(3):506-12. PubMed ID: 21093092
[TBL] [Abstract][Full Text] [Related]
20. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]